-
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Consensus Recommendation of "Moderate Buy" from Analysts
ソース: Buzz FX / 13 1 2025 04:50:15 America/New_York
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Outlook Therapeutics, Inc.
Read more...